AMY2A p.Pro69Thr
c.205C>A · VCV4640329
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2913 | likely benign |
|---|---|---|
| REVEL | 0.354 | indeterminate |
| SaProt | LLR -11.15 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | Δ0.20 | acceptor loss, 8 bp away · masked 0 · deltas |
| Constraint at this position | ||
| Conservation | phyloP 0.9 | GERP 1.7 |
| Regional constraint | o/e 0.94 | unconstrained · MANE · 1,667 bp · p 0.42 · regional, not allelic |
| Overall | ||
| CADD | 21.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.0055% | 18,172 |
| Remaining individualsnot grpmax-eligible | 0.00323% | 30,930 |
| African / African-American | 0.00134% | 74,604 |
| European (non-Finnish) | 8.54e-05% | 1,170,644 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- AMY2A
- Protein
- p.Pro69Thr
- Coding
- c.205C>A
- MANE Select
- NM_000699
- Type
- single nucleotide variant
- Location
- chr1:103617990 (GRCh38)
- Gene constraint
- LOEUF 0.848 · pLI 0.02 (gnomAD)
- Structure
- AlphaFold pLDDT 96.68 · 51 PDB
- Residue 69
- a disulfide bond; a turn
Similar variants
- AMY2A p.Asn120= Likely benign ★★ same type
- AMY2A p.Asn370= Benign/Likely benign ★★ same type
- AMY2A p.Thr99Asn Benign ★★ same type
- AMY2A p.Ala112Asp Uncertain significance ★ ⚠ same type
- AMY2A p.Ala121Thr Uncertain significance ★ ⚠ same type
- AMY2A p.Ala124Gly Uncertain significance ★ ⚠ same type
- AMY2A p.Ala65Thr Uncertain significance ★ ⚠ same type
- AMY2A p.Arg107Cys Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/amy2a-p-pro69thr (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown